Market closed · Oct 8, 7:20 am ET · Last extended-hours $25.54 0.00%
Open$25.91
Prev close$25.91
Day range$25.29 – $26.17
Volume776.3K
Market cap$1.09B
P/E (TTM)15.1
Dividend yield–
AMPH Stock News
Headlines matching Amphastar Pharmaceuticals or the AMPH ticker, most recent first.
Wells Fargo Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Raises Target Price to $20PositiveMarket news · 7 Aug 2026 · Direct mention
Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Announces Target Price $20Market news · 7 Aug 2026 · Direct mention
Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $20NegativeMarket news · 7 Aug 2026 · Direct mention
Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Raises Target Price to $23PositiveMarket news · 19 Aug 2026 · Direct mention
Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold RatingMarket news · 9 Jul 2026 · Direct mention
Amphastar Pharmaceuticals (AMPH) Gets a Hold From J.P. MorganTipRanks · 23 Jul 2026 · Direct mention
Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $20NegativeMarket news · 4 Jun 2026 · Direct mention
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Ardent Health Partners, Inc. (ARDT) and Amphastar Pharmaceuticals (AMPH)TipRanks · 3 Jun 2026 · Direct mention
BofA Securities Downgrades Amphastar Pharmaceuticals(AMPH.US) to Sell Rating, Cuts Target Price to $20NegativeMarket news · 29 Jun 2026 · Direct mention
Analysts Offer Insights on Healthcare Companies: Caris Life Sciences, Inc. (CAI), Amphastar Pharmaceuticals (AMPH) and Amylyx Pharmaceuticals Inc (AMLX)TipRanks · 8 May 2026 · Direct mention
Needham Downgrades Amphastar Pharmaceuticals(AMPH.US) to Hold RatingNegativeMarket news · 8 May 2026 · Direct mention
Wells Fargo Initiates Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Announces Target Price $19Market news · 14 May 2026 · Direct mention
Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $21NegativeMarket news · 11 May 2026 · Direct mention
Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $23NegativeMarket news · 8 Apr 2026 · Direct mention
Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $30Market news · 15 Apr 2026 · Direct mention
Discussion
No comments yet — be the first to weigh in on AMPH.
No comments yet — be the first to weigh in on AMPH.